Trident Texofab Ltd - 540726 - Compliance Certificate For The Half Year Ended 30/09/2019
Trident Texofab Limited has submitted compliance certificate for the half year ended 30.09.2019 in compliance of Regulation 7(3) of SEBI (LODR) Regulations, 2015. Kindly take the same on your record. Thank you. Trident Texofab Ltd - 540726 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MEHUL N AMARELIYADesignation :- Company Secretary and Compliance Officer Trident Texofab Ltd - 540726 - Shareholding for the Period Ended September 30, 2019
Trident Texofab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here Trident Texofab Ltd - 540726 - Statement Of Deviation Or Variation In Public Issue, Rights Issue, Preferential Issue Etc. For The Quarter Ended On September 30, 2019.
Trident Texofab Limited has submitted the statement of deviation or variation in public issue, rights issue, preferential issue etc. for the quarter ended on September 30, 2019. Kindly take the same on your record. Thank you. Trident Texofab Ltd - 540726 - Closure of Trading Window
Trident Texofab Limited has intimated to BSE that the trading window for dealing in equity shares of the company by all the designated persons will be closed from October 01, 2019 till 48 hours after the declaration of unaudited financial result for the quarter/half year ended on September 30, 2019. Please take the same on your records. Trident Texofab Ltd - 540726 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chetan Chandrakant Jariwala Trident Texofab Ltd - 540726 - Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations, 2011
Trident Texofab Limited has submitted disclosure received from Mr. Chetan C. Jariwala, one of promoter member under regulation 29 of SEBI SAST, Regulations, 2011 for acquisition of 5000 shares on 18.09.2019 from open market. Kindly take the same on record. Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Investor Presentation
Trident Texofab Limited has submitted investor presentation for the quarter ended on 30.06.2019. Kindly take on record. Trident Texofab Ltd - 540726 - Outcome of Board Meeting
Trident Texofab Limited has submitted outcome of the board meeting held on today i.e. 08.08.2019 including approval of unaudited financial result for the quarter ended on 30.06.2019. Trident Texofab Ltd - 540726 - Financial Result For The Quarter Ended On 30.06.2019
Trident Texofab Limited has submitted unaudited financial result for the quarter ended 30th June, 2019 which was approved by the board in its meeting held on today at 03.00 pm and concluded at 03.45 pm. Kindly take on record.